Business Description
Actuate Therapeutics is a Fort Worth, Texas-based company focused on developing new cancer treatments. Its main drug, elraglusib, is currently being tested in clinical trials for several difficult-to-treat cancers, including advanced pancreatic cancer and certain childhood cancers such as Ewing sarcoma, neuroblastoma, and pediatric leukemias. The company was founded in 2015 and has been building its research pipeline with the goal of bringing more effective options to patients with limited treatment choices.
